Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ontaneda

Showing results (61-70 of 193) with videos related to

Pageof 20
Sort By:
Multiple Sclerosis and Related Disorders|July 27, 2016
Relapse rates in patients with multiple sclerosis treated with fingolimod: Subgroup analyses of pooled data from three phase 3 trialsTobias Derfuss, Daniel Ontaneda, Jacqueline Nicholas, et al.
Current Neurology and Neuroscience Reports|June 28, 2024
Artificial Intelligence and Multiple SclerosisMoein Amin, Eloy Martínez-Heras, Daniel Ontaneda, et al.
Multiple Sclerosis and Related Disorders|August 3, 2025
Cognitive profiles associated with faster thalamic atrophy in multiple sclerosisMoein Amin, Keeley Scullin, Kunio Nakamura, et al.
Multiple Sclerosis and Related Disorders|August 25, 2019
Vitamin D and MRI measures in progressive multiple sclerosisJustin R Abbatemarco, Robert J Fox, Hong Li, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 20, 2019
Pregnancy and multiple sclerosis: Risk of unplanned pregnancy and drug exposure in uteroAndrew L Smith, Jeffrey A Cohen, Daniel Ontaneda, et al.
The Lancet. Neurology|November 9, 2019
Pragmatic clinical trials for treating relapsing multiple sclerosisEllen M Mowry, Daniel Ontaneda, Nikos Evangelou, et al.
The Lancet. Neurology|January 24, 2026
Patient-reported outcomes and multiple sclerosis therapiesPaola Zaratin, Daniel Ontaneda, Maria Pia Amato, et al.
The Lancet. Neurology|August 4, 2019
Early highly effective versus escalation treatment approaches in relapsing multiple sclerosisDaniel Ontaneda, Emma Tallantyre, Tomas Kalincik, et al.
Multiple Sclerosis and Related Disorders|February 22, 2023
"It's on the tip of my tongue!" exploring confrontation naming difficulties in patients with multiple sclerosisTiffany Grezmak, John W Lace, Kunio Nakamura, et al.
Medical Physics|March 21, 2025
Investigation of neuro-vascular reactivity on fMRI study during visual activation in people with multiple sclerosis using EEG and hypercapnia challengeWanyong Shin, Balu Krishnan, Ajay Nemani, et al.
Pageof 20

Showing results (61-70 of 193) with videos related to

Sort By:
Pageof 20
Multiple Sclerosis and Related Disorders|July 27, 2016
Relapse rates in patients with multiple sclerosis treated with fingolimod: Subgroup analyses of pooled data from three phase 3 trialsTobias Derfuss, Daniel Ontaneda, Jacqueline Nicholas, et al.
Current Neurology and Neuroscience Reports|June 28, 2024
Artificial Intelligence and Multiple SclerosisMoein Amin, Eloy Martínez-Heras, Daniel Ontaneda, et al.
Multiple Sclerosis and Related Disorders|August 3, 2025
Cognitive profiles associated with faster thalamic atrophy in multiple sclerosisMoein Amin, Keeley Scullin, Kunio Nakamura, et al.
Multiple Sclerosis and Related Disorders|August 25, 2019
Vitamin D and MRI measures in progressive multiple sclerosisJustin R Abbatemarco, Robert J Fox, Hong Li, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 20, 2019
Pregnancy and multiple sclerosis: Risk of unplanned pregnancy and drug exposure in uteroAndrew L Smith, Jeffrey A Cohen, Daniel Ontaneda, et al.
The Lancet. Neurology|November 9, 2019
Pragmatic clinical trials for treating relapsing multiple sclerosisEllen M Mowry, Daniel Ontaneda, Nikos Evangelou, et al.
The Lancet. Neurology|January 24, 2026
Patient-reported outcomes and multiple sclerosis therapiesPaola Zaratin, Daniel Ontaneda, Maria Pia Amato, et al.
The Lancet. Neurology|August 4, 2019
Early highly effective versus escalation treatment approaches in relapsing multiple sclerosisDaniel Ontaneda, Emma Tallantyre, Tomas Kalincik, et al.
Multiple Sclerosis and Related Disorders|February 22, 2023
"It's on the tip of my tongue!" exploring confrontation naming difficulties in patients with multiple sclerosisTiffany Grezmak, John W Lace, Kunio Nakamura, et al.
Medical Physics|March 21, 2025
Investigation of neuro-vascular reactivity on fMRI study during visual activation in people with multiple sclerosis using EEG and hypercapnia challengeWanyong Shin, Balu Krishnan, Ajay Nemani, et al.
Pageof 20